Total Payments
$17,991
2024 Payments
$1,602
Companies
36
Transactions
374
Medicare Patients
674
Medicare Billing
$40,057
Payment Breakdown by Category
Food & Beverage$7,036 (39.1%)
Education$6,235 (34.7%)
Travel$4,720 (26.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,036 | 333 | 39.1% |
| Education | $6,235 | 25 | 34.7% |
| Travel and Lodging | $4,720 | 16 | 26.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Intuitive Surgical, Inc. | $7,297 | 12 | $0 (2019) |
| COLOPLAST CORP | $2,191 | 23 | $0 (2024) |
| Boston Scientific Corporation | $1,258 | 9 | $0 (2024) |
| Ferring Pharmaceuticals Inc. | $1,236 | 12 | $0 (2018) |
| Medtronic USA, Inc. | $1,194 | 81 | $0 (2020) |
| Medtronic, Inc. | $924.00 | 42 | $0 (2024) |
| AbbVie Inc. | $775.06 | 45 | $0 (2023) |
| Astellas Pharma US Inc | $489.71 | 27 | $0 (2023) |
| Allergan, Inc. | $373.80 | 11 | $0 (2020) |
| TherapeuticsMD, Inc. | $313.24 | 19 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,602 | 16 | Boston Scientific Corporation ($969.64) |
| 2023 | $552.62 | 25 | Astellas Pharma US Inc ($211.81) |
| 2022 | $972.00 | 45 | Medtronic, Inc. ($244.93) |
| 2021 | $978.59 | 54 | Medtronic, Inc. ($380.63) |
| 2020 | $709.51 | 41 | AbbVie Inc. ($235.71) |
| 2019 | $1,657 | 49 | Intuitive Surgical, Inc. ($774.53) |
| 2018 | $2,443 | 75 | Ferring Pharmaceuticals Inc. ($1,236) |
| 2017 | $9,077 | 69 | Intuitive Surgical, Inc. ($6,522) |
All Payment Transactions
374 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/07/2024 | Minerva Surgical, Inc | — | Food and Beverage | In-kind items and services | $39.90 | General |
| Category: Ablation System | ||||||
| 11/06/2024 | Minerva Surgical, Inc | — | Food and Beverage | In-kind items and services | $33.90 | General |
| Category: Ablation System | ||||||
| 10/24/2024 | Cosette Pharmaceuticals Inc. | Vyleesi (Drug) | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: Sexual wellness | ||||||
| 10/23/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: UROLOGY | ||||||
| 09/13/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: UROLOGY | ||||||
| 08/12/2024 | MILLICENT US INC | FEMRING (Drug), INTRAROSA | Food and Beverage | In-kind items and services | $21.14 | General |
| Category: TREAT SYMPTOMS OF MENOPAUSE | ||||||
| 08/12/2024 | MILLICENT US INC | — | Education | In-kind items and services | $13.35 | General |
| 07/31/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: HORMONE THERAPY | ||||||
| 05/29/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $156.33 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 04/24/2024 | MAYNE PHARMA COMMERCIAL LLC | NEXTSTELLIS (Drug) | Food and Beverage | In-kind items and services | $121.82 | General |
| Category: CONTRACEPTIVE | ||||||
| 03/22/2024 | Boston Scientific Corporation | Solyx SIS System (Device) | Travel and Lodging | In-kind items and services | $150.00 | General |
| Category: Solyx_URO | ||||||
| 03/21/2024 | Boston Scientific Corporation | Solyx SIS System (Device) | Travel and Lodging | In-kind items and services | $733.21 | General |
| Category: Solyx_URO | ||||||
| 03/21/2024 | Boston Scientific Corporation | Solyx SIS System (Device) | Food and Beverage | In-kind items and services | $86.43 | General |
| Category: Solyx_URO | ||||||
| 03/19/2024 | COLOPLAST CORP | Titan (Device) | Food and Beverage | In-kind items and services | $146.13 | General |
| Category: Men's Health | ||||||
| 03/13/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $6.41 | General |
| 02/22/2024 | PFIZER INC. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $21.99 | General |
| Category: GENITOURINARY (SEXUAL HEALTH);WOMENS HEALTH | ||||||
| 12/13/2023 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $7.53 | General |
| 12/13/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $7.06 | General |
| Category: Biological | ||||||
| 11/07/2023 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $17.83 | General |
| 10/06/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $6.74 | General |
| Category: Biological | ||||||
| 09/19/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $123.63 | General |
| Category: Biological | ||||||
| 09/06/2023 | Hologic Sales and Service, LLC | THINPREP 2000 PROCESSOR (Device), APTIMA | Food and Beverage | In-kind items and services | $12.95 | General |
| Category: Diagnostics | ||||||
| 09/05/2023 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $16.49 | General |
| 08/07/2023 | AbbVie Inc. | LO LOESTRIN FE (Drug) | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: WOMENS HEALTH | ||||||
| 08/03/2023 | Avion Pharmaceuticals | Balcoltra (Drug) | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: Oral Contraceptive | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 135 | 151 | $24,280 | $7,788 |
| 2022 | 4 | 181 | 203 | $33,325 | $11,219 |
| 2021 | 5 | 193 | 220 | $37,940 | $12,455 |
| 2020 | 5 | 165 | 190 | $29,415 | $8,594 |
Total Patients
674
Total Services
764
Medicare Billing
$40,057
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 44 | 55 | $10,175 | $3,444 | 33.8% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 47 | 47 | $5,170 | $1,817 | 35.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 20 | 20 | $5,600 | $1,511 | 27.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 24 | 29 | $3,335 | $1,016 | 30.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 59 | 72 | $13,320 | $4,763 | 35.8% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 68 | 68 | $7,480 | $2,672 | 35.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 32 | 32 | $8,960 | $2,543 | 28.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 22 | 31 | $3,565 | $1,242 | 34.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 40 | 50 | $9,250 | $3,494 | 37.8% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 41 | 41 | $11,480 | $3,061 | 26.7% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 43 | 60 | $6,900 | $2,365 | 34.3% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 53 | 53 | $5,830 | $2,085 | 35.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 16 | 16 | $4,480 | $1,451 | 32.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 40 | 47 | $8,695 | $2,464 | 28.3% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 27 | 27 | $7,560 | $1,999 | 26.4% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 42 | 60 | $6,900 | $1,861 | 27.0% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2020 | 44 | 44 | $4,840 | $1,748 | 36.1% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2020 | 12 | 12 | $1,420 | $520.98 | 36.7% |
About Dr. Thomas Easter, M.D
Dr. Thomas Easter, M.D is a Gynecology healthcare provider based in Rancho Cucamonga, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1922038595.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Easter, M.D has received a total of $17,991 in payments from pharmaceutical and medical device companies, with $1,602 received in 2024. These payments were reported across 374 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($7,036).
As a Medicare-enrolled provider, Easter has provided services to 674 Medicare beneficiaries, totaling 764 services with total Medicare billing of $40,057. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Gynecology
- Other Specialties Obstetrics
- Location Rancho Cucamonga, CA
- Active Since 07/03/2006
- Last Updated 03/30/2023
- Taxonomy Code 207VG0400X
- Entity Type Individual
- NPI Number 1922038595
Products in Payments
- Da Vinci Surgical System (Device) $7,297
- INTERSTIM (Device) $2,118
- FEMALE INCONTINENCE (Device) $1,369
- Solyx SIS System (Device) $1,011
- LO LOESTRIN FE (Drug) $394.58
- ALTIS (Device) $244.65
- PELVIC FLOOR REPAIR (Device) $196.08
- ORILISSA (Drug) $171.28
- Myrbetriq (Drug) $157.59
- Veozah (Drug) $151.96
- ANNOVERA (Drug) $151.95
- LILETTA (Drug) $147.40
- Titan (Device) $146.13
- SOLYX (Device) $146.03
- PREMARIN ORALS (Drug) $139.64
- MYFEMBREE (Drug) $130.87
- TISSEEL (Device) $123.80
- Altis (Device) $123.18
- NEXTSTELLIS (Drug) $121.82
- Contained Tissue Extraction Syst (Device) $121.15
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.